相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。High levels of serum TIMP-1 correlate with advanced disease and predict for poor survival in patients with multiple myeloma treated with novel agents
Evangelos Terpos et al.
LEUKEMIA RESEARCH (2010)
Treatment of Multiple Myeloma in the Targeted Therapy Era
Ayman A. Saad et al.
ANNALS OF PHARMACOTHERAPY (2009)
A monoclonal gammopathy precedes multiple myeloma in most patients
Brendan M. Weiss et al.
BLOOD (2009)
Monoclonal gammopathy of undetermined significance (MGUS) consistently precedes multiple myeloma: a prospective study
Ola Landgren et al.
BLOOD (2009)
Dominant role of CD47-thrombospondin-1 interactions in myeloma-induced fusion of human dendritic cells: implications for bone disease
Anjli Kukreja et al.
BLOOD (2009)
Macrophages are an abundant component of myeloma microenvironment and protect myeloma cells from chemotherapy drug-induced apoptosis
Yuhuan Zheng et al.
BLOOD (2009)
Small Integrin-Binding Proteins as Serum Markers for Prostate Cancer Detection
Alka Jain et al.
CLINICAL CANCER RESEARCH (2009)
Gene Expression Profiling of Bone Marrow Endothelial Cells in Patients with Multiple Myeloma
Roberto Ria et al.
CLINICAL CANCER RESEARCH (2009)
Altered Expression of Fibronectin and Collagens I and IV in Multiple Myeloma and Monoclonal Gammopathy of Undetermined Significance
Tara M. Tancred et al.
JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY (2009)
Bone-marrow adipocytes as negative regulators of the haematopoietic microenvironment
Olaia Naveiras et al.
NATURE (2009)
Autologous Hematopoietic Stem-Cell Transplantation for Multiple Myeloma
Jean-Luc Harousseau et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Role of decorin in the antimyeloma effects of osteoblasts
Xin Li et al.
BLOOD (2008)
Myeloma-derived Dickkopf-1 disrupts Wnt-regulated osteoprotegerin and RANKL production by osteoblasts: a potential mechanism underlying osteolytic bone lesions in multiple myeloma
Ya-Wei Qiang et al.
BLOOD (2008)
Dendritic cells mediate the induction of polyfunctional human IL17-producing cells (Th17-1 cells) enriched in the bone marrow of patients with myeloma
Kavita M. Dhodapkar et al.
BLOOD (2008)
Matrix metalloproteinases-1 and-2, and tissue inhibitor of metalloproteinase-2 production is abnormal in bone marrow stromal cells of multiple myeloma patients
Barbara Zdzisinska et al.
LEUKEMIA RESEARCH (2008)
Stromal Gene Signatures in Large-B-Cell Lymphomas
G. Lenz et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Osteoblastic regulation of B lymphopoiesis is mediated by Gsα-dependent signaling pathways
Joy Y. Wu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
MT1-MMP is required for efficient tumor dissemination in experimental metastatic disease
L. Szabova et al.
ONCOGENE (2008)
Vasculogenic mimicry by bone marrow macrophages in patients with multiple myeloma
C. Scavelli et al.
ONCOGENE (2008)
Pathophysiology of myeloma bone disease
Flavia R. Esteve et al.
BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY (2007)
Self-renewing osteoprogenitors in bone marrow sinusoids can organize a hematopoietic microenvironment
Benedetto Sacchetti et al.
CELL (2007)
Myeloma bone-disease and proteasome inhibition therapies
Evangelos Terpos et al.
BLOOD (2007)
Body mass index, physical activity, and risk of multiple myeloma
Brenda M. Birmann et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2007)
Review of molecular diagnostics in multiple myeloma
A. Keith Stewart et al.
EXPERT REVIEW OF MOLECULAR DIAGNOSTICS (2007)
Phenotypic and functional characterization of bone marrow mesenchymal stem cells derived from patients with multiple myeloma
B. Arnulf et al.
LEUKEMIA (2007)
The differentiation and stress response factor XBP-1 drives multiple myeloma pathogenesis
Daniel R. Carrasco et al.
CANCER CELL (2007)
Multiple myeloma bone disease: pathophysiology of osteoblast inhibition
Nicola Giuliani et al.
BLOOD (2006)
Maintenance of the hematopoietic stem cell pool by CXCL12-CXCR4 chemokine signaling in bone marrow stromal cell niches
Tatsuki Sugiyama et al.
IMMUNITY (2006)
Heparan sulphate proteoglycans are essential for the myeloma cell growth activity of EGF-family ligands in multiple myeloma
K. Mahtouk et al.
ONCOGENE (2006)
Enhancement of clonogenicity of human multiple myeloma by dendritic cells
Anjli Kukreja et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2006)
Importance of the bone marrow microenvironment in inducing the angiogenic response in multiple myeloma
D. Ribatti et al.
ONCOGENE (2006)
Role of B-cell-activating factor in adhesion and growth of human multiple myeloma cells in the bone marrow microenvironment
Yu-Tzu Tai et al.
CANCER RESEARCH (2006)
Angiogenesis in multiple myeloma
Christian Jakob et al.
EUROPEAN JOURNAL OF CANCER (2006)
Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells
E Bettelli et al.
NATURE (2006)
Heparan sulfate in trans potentiates VEGFR-mediated angiogenesis
Lars Jakobsson et al.
DEVELOPMENTAL CELL (2006)
Regulation, function and clinical significance of heparanase in cancer metastasis and angiogenesis
Neta Ilan et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2006)
Myeloma cells suppress bone formation by secreting a soluble Wnt inhibitor, sFRP-2
T Oshima et al.
BLOOD (2005)
IL-3 is a potential inhibitor of osteoblast differentiation in multiple myeloma
LA Ehrlich et al.
BLOOD (2005)
The level of TACI gene expression in myeloma cells is associated with a signature of microenvironment dependence versus a plasmablastic signature
J Moreaux et al.
BLOOD (2005)
Circulating endothelial progenitor cells in multiple myeloma:: implications and significance
H Zhang et al.
BLOOD (2005)
The pathophysiologic role of VEGF in hematologic malignancies: therapeutic implications
K Podar et al.
BLOOD (2005)
Tissue inhibitor of metalloproteinase 1 (TIMP-1) promotes plasmablastic differentiation of a Burkitt lymphoma cell line: implications in the pathogenesis of plasmacytic/plasmablastic tumors
L Guedez et al.
BLOOD (2005)
Calcium-sensing receptor activation stimulates parathyroid hon-none-related protein secretion in prostate cancer cells: role of epidermal growth factor receptor transactivation
S Yano et al.
BONE (2004)
Advances in biology of multiple myeloma: clinical applications
T Hideshima et al.
BLOOD (2004)
Insulin-like growth factor I induces migration and invasion of human multiple myeloma cells
YW Qiang et al.
BLOOD (2004)
Drug therapy: Multiple myeloma
RA Kyle et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Bone marrow endothelial cells increase the invasiveness of human multiple myeloma cells through upregulation of MMP-9: evidence for a role of hepatocyte growth factor
IV Broek et al.
LEUKEMIA (2004)
The role of the Wnt-signaling antagonist DKK1 in the development of osteolytic lesions in multiple myeloma
E Tian et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Osteoblastic cells regulate the haematopoietic stem cell niche
LM Calvi et al.
NATURE (2003)
Tissue inhibitor of metalloproteinases-1 (TIMP-1) inhibits tumor growth and angiogenesis in the TIMP-1 transgenic mouse model
Y Ikenaka et al.
INTERNATIONAL JOURNAL OF CANCER (2003)
A reversible defect in natural killer T cell function characterizes the progression of premalignant to malignant multiple myeloma
MV Dhodapkar et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2003)
β2-Microglobulin as a negative regulator of the immune system:: high concentrations of the protein inhibit in vitro generation of functional dendritic cells
J Xie et al.
BLOOD (2003)
Continuous absence of metaphase-defined cytogenetic abnormalities, especially of chromosome 13 and hypodiploidy, ensures long-term survival in multiple myeloma treated with total therapy I: interpretation in the context of global gene expression
J Shaughnessy et al.
BLOOD (2003)
Macrophage inflammatory protein 1-alpha (MIP-1α) triggers migration and signaling cascades mediating survival and proliferation in multiple myeloma (MM) cells
S Lentzsch et al.
BLOOD (2003)
Identification of genes regulated by 2-methoxyestradiol (2ME2) in multiple myeloma cells using oligonucleotide arrays
D Chauhan et al.
BLOOD (2003)
Plasma cell differentiation and the unfolded protein response intersect at the transcription factor XBP-1
NN Iwakoshi et al.
NATURE IMMUNOLOGY (2003)
Transformation of a MGUS to overt multiple myeloma: The possible role of a pituitary macroadenoma secreting high levels of insulin-like growth factor 1 (IGF-1)
A Tucci et al.
LEUKEMIA & LYMPHOMA (2003)
The extracellular calcium (Cao2+)-sensing receptor is expressed in myeloma cells and modulates cell proliferation
T Yamaguchi et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2002)
Serum insulinlike growth factor is not elevated in patients with multiple myeloma but is still a prognostic factor
T Standal et al.
BLOOD (2002)
Enforced expression of tissue inhibitor of matrix metalloproteinase-3 affects functional capillary morphogenesis and inhibits tumor growth in a murine tumor model
WW Spurbeck et al.
BLOOD (2002)
Upregulation of matrix metalloproteinase-9 in murine 5T33 multiple myeloma cells by interaction with bone marrow endothelial cells
E Van Valckenborgh et al.
INTERNATIONAL JOURNAL OF CANCER (2002)
Didox (A novel ribonucleotide reductase inhibitor) overcomes bcl-2 mediated radiation resistance in prostate cancer cell line PC-3
MS Inayat et al.
CANCER BIOLOGY & THERAPY (2002)
Matrix metalloproteinases and their role in pancreatic cancer: A review of preclinical studies and clinical trials
M Bloomston et al.
ANNALS OF SURGICAL ONCOLOGY (2002)
Soluble syndecan-1 promotes growth of myeloma tumors in vivo
Y Yang et al.
BLOOD (2002)
Dendritic cells are functionally defective in multiple myeloma: the role of interleukin-6
M Ratta et al.
BLOOD (2002)
Matrix metalloproteinases in cancer:: Prognostic markers and therapeutic targets
P Vihinen et al.
INTERNATIONAL JOURNAL OF CANCER (2002)
Murine 5T multiple myeloma cells induce angiogenesis in vitro and in vivo
E Van Valckenborgh et al.
BRITISH JOURNAL OF CANCER (2002)
A long-term study of prognosis in monoclonal gammopathy of undetermined significance
RA Kyle et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Cell surface proteoglycan syndecan-1 mediates hepatocyte growth factor binding and promotes Met signaling in multiple myeloma
PWB Derksen et al.
BLOOD (2002)
Multiple myeloma: Evolving genetic events and host interactions
WM Kuehl et al.
NATURE REVIEWS CANCER (2002)
Translocation of Ku86/Ku70 to the multiple myeloma cell membrane: Functional implications
YT Tai et al.
EXPERIMENTAL HEMATOLOGY (2002)
Mechanisms involved in the differential bone marrow homing of CD45 subsets in 5T murine models of myeloma
K Asosingh et al.
CLINICAL & EXPERIMENTAL METASTASIS (2002)
Dendritic cells from patients with myeloma are numerically normal but functionally defective as they fail to up-regulate CD80 (B7-1) expression after huCD40LT stimulation because of inhibition by transforming growth factor-β1 and interleukin-10
RD Brown et al.
BLOOD (2001)
Syndecan-1 (CD138) immunoreactivity in bone marrow biopsies of multiple myeloma: Shed syndecan-1 accumulates in fibrotic regions
IB Bayer-Garner et al.
MODERN PATHOLOGY (2001)
Biologic sequelae of interleukin-6 induced P13-K/Akt signaling in multiple myeloma
T Hideshima et al.
ONCOGENE (2001)
The expression profile of matrix metalloproteinases (MMPs) and their inhibitors (TIMPs) in lesions and normal appearing white matter of multiple sclerosis
RLP Lindberg et al.
BRAIN (2001)
αvβ3 integrin engagement modulates cell adhesion, proliferation, and protease secretion in human lymphoid tumor cells
A Vacca et al.
EXPERIMENTAL HEMATOLOGY (2001)
Plasma cell differentiation requires the transcription factor XBP-1
AM Reimold et al.
NATURE (2001)
Vascular endothelial growth factor triggers signaling cascades mediating multiple myeloma cell growth and migration
K Podar et al.
BLOOD (2001)
Expression and induction of collagenases (MMP-8 and-13) in plasma cells associated with bone-destructive lesions
J Wahlgren et al.
JOURNAL OF PATHOLOGY (2001)
Severe and long-lasting disruption of T-cell receptor diversity in human myeloma after high-dose chemotherapy and autologous peripheral blood progenitor cell infusion
S Mariani et al.
BRITISH JOURNAL OF HAEMATOLOGY (2001)
Hyaluronic acid induces survival and proliferation of human myeloma cells through an interleukin-6-mediated pathway involving the phosphorylation of retinoblastoma protein
T Vincent et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Serum bone sialoprotein as a marker of tumour burden and neoplastic bone involvement and as a prognostic factor in multiple myeloma
HW Woitge et al.
BRITISH JOURNAL OF CANCER (2001)
Adhesion to fibronectin via β1 integrins regulates p27kip1 levels and contributes to cell adhesion mediated drug resistance (CAM-DR)
LA Hazlehurst et al.
ONCOGENE (2000)
Expression of urokinase plasminogen activator and the urokinase plasminogen activator receptor in myeloma cells
Ö Hjertner et al.
BRITISH JOURNAL OF HAEMATOLOGY (2000)
Binding of active (57 kDa) membrane type 1-matrix metalloproteinase (MT1-MMP) to tissue inhibitor of metalloproteinase (TIMP)-2 regulates MT1-MMP processing and pro-MMP-2 activation
S Hernandez-Barrantes et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
分享论文
